Can serologic markers of fibrosis reveal an arrhythmogenic ventricular substrate in nonischemic dilated cardiomyopathy?
Marcus
Gregory M
GM
D015415:Biomarkers / Q000097:blood*; D002311:Cardiomyopathy, Dilated / Q000097:blood* / Q000209:etiology / Q000628:therapy; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D017147:Defibrillators, Implantable; D018450:Disease Progression; D004554:Electric Countershock / Q000295:instrumentation*; D004719:Endomyocardial Fibrosis / Q000097:blood* / Q000150:complications / Q000503:physiopathology; D006801:Humans; D011379:Prognosis; D016277:Ventricular Function, Left / Q000502:physiology
D015415:Biomarkers